level-one heading

Writers
Data Analysts
Consultants
Product Developers
Researchers
Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 100 /hr
Hire Dr. Minal J.
India
USD 100 /hr

Health Economic Modeler & HEOR specialist | Expert in HTA submission | 15 years' experience in HEOR

Profile Summary
Subject Matter Expertise
Services
Writing Medical Writing, Technical Writing
Research Market Research, Feasibility Study, Gap Analysis, Gray Literature Search, Scientific and Technical Research, Systematic Literature Review, Secondary Data Collection
Consulting Business Strategy Consulting, Healthcare Consulting, Scientific and Technical Consulting
Data & AI Predictive Modeling, Statistical Analysis, Data Visualization
Work Experience

Team Lead

Novartis Healthcare Private Limited

January 2021 - January 2023

Senior Manager

Novartis Healthcare Private Limited

September 2018 - December 2020

Manager

Novartis Healthcare Private Limited

September 2015 - August 2018

Senior Analyst - Healtheconomics

Novartis Healthcare Private Limited

August 2013 - August 2018

Senior Stroke Research Fellow

University of Rochester Medical Center

June 2010 - June 2013

Departmental Fellow

University of Rochester Medical Center

October 2009 - May 2010

Research trainee

University of Rochester Medical Center

July 2009 - October 2009

Education

MPH

University of Rochester Medical Centre

January 2010 - August 2012

Medical Degree (MD)

MUHS

August 2003 - May 2009

Certifications

  • Certified in Public Health

    National Board of Public Health Examiners

    January 2024 - Present

Publications
JOURNAL ARTICLE
Cesarius Wahono, Laniyati Hamijoyo, Hendrawan Y, Rakinaturia L, Mittal N, Khanna P, Jain M, Isbagio H (2023). Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective . PharmacoEconomics - open.
S Moreno, S Walsh, PJ Khanna, M Jain, N Tanova-Yotova (2022). EE186 Assessment of the Cost-Effectiveness of Secukinumab Versus Risankizumab for the Treatment of Adults With Moderate-to-Severe Plaque Psoriasis in the UK . Value in Health.
(2021). Canadian Rheumatology Association Meeting Virtual Congress February 24 – 26, 2021 . The Journal of Rheumatology.
Philip Hampton, Anna Halliday, Aassi M, Subhashini Subramanian, Jain M, Griffiths CEM (2021). Twelve-week secukinumab treatment is consistently efficacious for moderate-to-severe psoriasis regardless of prior biologic and non-biologic systemic treatment: Post hoc analysis of six randomised trials . Journal of the European Academy of Dermatology and Venereology : JEADV.
J. Gratacós, J.M. Martínez-Sesmero, M. Jain, A. Yocolly, P. Gunda, C. Blanch (2019). PBI14 COST-EFFECTIVENESS OF SECUKINUMAB VERSUS OTHER BIOLOGICS AND APREMILAST IN THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS: A SPANISH PERSPECTIVE . Value in Health.
Timo Purmonen, Puolakka K, Devarshi Bhattacharyya, Jain M, Martikainen J (2018). Cost-effectiveness analysis of secukinumab versus other biologics and apremilast in the treatment of active Psoriatic arthritis: a Finnish perspective . Cost effectiveness and resource allocation : C/E.
Goeree R, Chiva-Razavi S, Gunda P, Jain M, Jugl SM (2018). Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective . Journal of medical economics.
M Jain, TK Nallagangula, S Jawla, N Rai, D Dev, S Weber, N Cook (2015). Heterogeneity in Relative Efficacy Assessments (Rea) across European Hta Bodies: Opportunity for Improving Efficiency and Speed of Access to Patients? . Value in Health.
Damania D, Kung NT, Jain M, Jain AR, Jason Liew, Rajiv Mangla, Koch GE, Sahin B, Miranpuri AS, Holmquist TM, et al. (2015). Factors associated with recurrent stroke and recanalization in patients presenting with isolated symptomatic carotid occlusion . European journal of neurology.
Gallati CP, Jain M, Damania D, Kanthala AR, Jain AR, Koch GE, Kung NT, Wang HZ, Replogle RE, Babak S. Jahromi (2015). 64-detector CT angiography within 24 hours after carotid endarterectomy and correlation with postoperative stroke . Journal of neurosurgery.
M. Jain, S. Bhattacharyya, S. Gupta, V. Sonathi, R. Mahon, H. Malakar, U. Vudumala, P. Gunda, P. Kumar, G. Partha, et al. (2014). How Does Uncertainty Around Costs And Effects Relate To Uncertainty Around Cost-Effectiveness? . Value in Health.
Jain M, Sonathi V, Rathi H, Thomas SK, Mollon P (2014). The Economic Impact Of Cardiovascular Events In Patients Post Myocardial Infarction: Uk Health Care Perspective . Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
Minal Jain, Jonathan Jay Stone, Corey Walker, Maxwell Jacobson, Valerie Phillips, Howard J. Silberstein (2014). 112 Shunt Survival Benefit Associated With Complete vs Partial Revision . Neurosurgery.
Minal Jain, Dushyant Damania, Anunaya Jain, Abhijit Kanthala, Latha Stead, Babk Jahromi (2014). Does Prolonged Length of Stay in the Emergency Department Affect Outcome for Stroke Patients? . Western Journal of Emergency Medicine.
Minal Jain, Kate C. Young, Anunaya Jain, Robert E. Replogle, Curtis G. Benesch, Babak S. Jahromi (2011). Evidence-based treatment of carotid artery stenosis . Neurosurgical Focus.